Varicella vaccine dose depended effectiveness and waning among preschool children in Hong Kong

In Hong Kong, universal varicella vaccination was introduced in July 2014 with a two-dose schedule but the vaccines had been available in the private market since 1996. With data from varicella notification and surveys on immunization coverage, we used the screening method to estimate dose-specific...

Full description

Saved in:
Bibliographic Details
Main Authors: Yung-Wai Desmond Chan (Author), W John Edmunds (Author), Hong-Lam Chan (Author), Miu-Ling Wong (Author), Ka-Wing Albert Au (Author), Shuk-Kwan Chuang (Author), Albert Jan van Hoek (Author), Stefan Flasche (Author)
Format: Book
Published: Taylor & Francis Group, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_cdcb702d9c19483e94e66e97c16da8cb
042 |a dc 
100 1 0 |a Yung-Wai Desmond Chan  |e author 
700 1 0 |a W John Edmunds  |e author 
700 1 0 |a Hong-Lam Chan  |e author 
700 1 0 |a Miu-Ling Wong  |e author 
700 1 0 |a Ka-Wing Albert Au  |e author 
700 1 0 |a Shuk-Kwan Chuang  |e author 
700 1 0 |a Albert Jan van Hoek  |e author 
700 1 0 |a Stefan Flasche  |e author 
245 0 0 |a Varicella vaccine dose depended effectiveness and waning among preschool children in Hong Kong 
260 |b Taylor & Francis Group,   |c 2020-03-01T00:00:00Z. 
500 |a 2164-5515 
500 |a 2164-554X 
500 |a 10.1080/21645515.2019.1663121 
520 |a In Hong Kong, universal varicella vaccination was introduced in July 2014 with a two-dose schedule but the vaccines had been available in the private market since 1996. With data from varicella notification and surveys on immunization coverage, we used the screening method to estimate dose-specific varicella vaccine effectiveness (VE) among preschool children in Hong Kong before universal vaccination. We estimated the VE of one- and two-dose varicella vaccination against all notified varicella as 69.4% (95% confidence interval (95% CI) 69.5-71.2) and 93.4% (95% CI 91.7-94.7), respectively. We found that VE did not decrease with time since receipt. Varicella vaccine was more effective against complications (85.4% [95% CI 48.8-95.8] for one dose and 100% [95% CI -Inf to 100] for two doses) and against hospital admission (75.2% [95% CI 53.4-86.8] for one dose and 93.1% [95% CI 47.1-99.1] for two doses). Lower protection of one-dose varicella vaccine resulted in breakthrough varicella. Under universal vaccination, second-dose varicella vaccine (given as combined measles, mumps, rubella and varicella vaccine) was first scheduled for children when they reach primary one (about 6 years of age) and was recently advanced to 18 months of age. Shortening the interval between the first dose and second dose of varicella vaccination should reduce breakthrough varicella and outbreaks in preschool. 
546 |a EN 
690 |a chickenpox 
690 |a chickenpox vaccine 
690 |a immunity 
690 |a vaccine effectiveness 
690 |a Immunologic diseases. Allergy 
690 |a RC581-607 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Human Vaccines & Immunotherapeutics, Vol 16, Iss 3, Pp 499-505 (2020) 
787 0 |n http://dx.doi.org/10.1080/21645515.2019.1663121 
787 0 |n https://doaj.org/toc/2164-5515 
787 0 |n https://doaj.org/toc/2164-554X 
856 4 1 |u https://doaj.org/article/cdcb702d9c19483e94e66e97c16da8cb  |z Connect to this object online.